Appointment of Mr. Dinesh Chauhan as additional independent director of the company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals' board, at its December 30, 2025 meeting, approved the appointment of Mr. Dinesh Chauhan (DIN: 11456530) as an Additional Non-Executive Independent Director for a three-year term, subject to shareholder approval. At the same meeting, the board accepted the resignation of Ms. Bhoomi Patel as Independent Director, effective December 30, 2025, citing personal reasons. Mr. Chauhan, who has over 7 years of business management experience, will serve as Chairperson of the Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee, with the boards of these committees also reconstituted accordingly. The board meeting ran from 6:30 PM to 7:10 PM.
This is a routine board-level reshuffle with one independent director replacing another on the same day, so there is no material change in board composition or governance direction. Shareholders should note the appointment is subject to approval at the next Annual General Meeting.